2000
DOI: 10.1002/1098-1004(200011)16:5<446::aid-humu14>3.0.co;2-y
|View full text |Cite
|
Sign up to set email alerts
|

Recurrent and novel mutations of GCDH gene in Chinese glutaric acidemia type I families

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
0

Year Published

2002
2002
2023
2023

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 29 publications
(12 citation statements)
references
References 9 publications
0
12
0
Order By: Relevance
“…Macrocephaly, characteristic neuroimaging findings and urine organic acid analysis suggested the diagnosis of GA-I. Molecular genetic testing confirmed that she was compound heterozygote for the common R402W (c.1204C>T) mutation and the novel mutation IVS10-2A>G (c.1244A>G) at the same nucleotide position as the IVS10-2A>C mutation previously reported exclusively in Far Eastern populations (Busquets et al 2000a;Tang et al 2000;Shu et al 2003).…”
Section: Introductionmentioning
confidence: 51%
See 2 more Smart Citations
“…Macrocephaly, characteristic neuroimaging findings and urine organic acid analysis suggested the diagnosis of GA-I. Molecular genetic testing confirmed that she was compound heterozygote for the common R402W (c.1204C>T) mutation and the novel mutation IVS10-2A>G (c.1244A>G) at the same nucleotide position as the IVS10-2A>C mutation previously reported exclusively in Far Eastern populations (Busquets et al 2000a;Tang et al 2000;Shu et al 2003).…”
Section: Introductionmentioning
confidence: 51%
“…Despite the paucisymptomatic status of this patient, MRI showed white matter disease. Molecular genetic analysis of the GCDH revealed compound heterozygosity for the common R402W (p.Arg402Trp) mutation and a novel mutation, IVS10-2A>G, at a nucleotide position previously known to be mutated (IVS10-2A>C) exclusively in patients of Chinese/ Taiwanese origin (Busquets et al 2000a;Tang et al 2000;Shu et al 2003). Based on the results of urine organic acid analysis, the patient being a high excretor of GA and 3OHGA, we could only deduce a genotype-biochemical phenotype correlation, and we hypothesize that the novel pathogenic mutation in the GCDH gene described in this case report (c.1244A>G transversion; IVS10-2A>G) does not alleviate the effect of the common R402W mutation on residual GCDH activity and metabolite excretory profile.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The disorder generally presents in early childhood with the majority of children having no measurable enzyme activity. The estimated prevalence varies from 1 in 30,000 newborns in one Scandinavian study to 1 in 30,000 -100,000 newborns in other studies [2][3][4][5]. The prevalence may be much higher in isolated populations in the Middle East countries due to higher rates of consanguinity [6,7].…”
Section: Introductionmentioning
confidence: 97%
“…Mutations in the glutaryl-CoA dehydrogenase (GCDH) gene result in glutaryl-CoA dehydrogenase (Enzyme Commission number 1.3.8.6) deficiency which is a key enzyme in the catabolic pathways of the amino acids lysine, hydroxylysine, and tryptophan. The estimated prevalence is 1 in 30,000-100,000 newborns whereas this prevalence might be much higher in some countries with high rates of consanguineous marriages (Tang et al 2000;Strauss et al 2003;K€ olker et al 2006Baradaran et al 2014). GCDH deficiency is characterized by increased levels of organic acid excretions; namely of glutaric acid, 3-hydroxyglutaric acid (3-OHGA), glutaconic acid in urine and glutarylcarnitine in plasma.…”
Section: Introductionmentioning
confidence: 99%